Company Filing History:
Years Active: 2021
Title: The Innovative Contributions of Stephen Schilling
Introduction
Stephen Schilling is a notable inventor based in Halle, Germany. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on inhibitors of meprin α and β. His research focuses on developing novel hydroxamic acid derivatives that have potential therapeutic applications.
Latest Patents
Stephen Schilling holds a patent for his invention titled "Inhibitors of meprin α and β." This patent relates to novel hydroxamic acid derivatives that serve as inhibitors of meprin β and/or α. The invention includes pharmaceutical compositions comprising these compounds, as well as methods for the treatment or prophylaxis of diseases or conditions associated with meprin β and/or α.
Career Highlights
Stephen Schilling is currently associated with Vivoryon Therapeutics AG, a company dedicated to advancing innovative therapeutic solutions. His work at Vivoryon Therapeutics AG has positioned him as a key player in the development of new pharmaceutical treatments.
Collaborations
Stephen collaborates with talented professionals in his field, including Michael Wermann and Mirko Buchholz. These collaborations enhance the research and development efforts at Vivoryon Therapeutics AG.
Conclusion
Stephen Schilling's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments.